Skip to main content
1435 search results for:

Alopecia Areata 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-07-2024 | Alopecia Areata | Letter

    Bidirectional association between alopecia areata and prurigo nodularis: a population-based cohort study using TriNetX

  2. 11-03-2024 | Minoxidil | ReviewPaper

    Treatment Options for Alopecia Areata in Children and Adolescents

    Alopecia areata (AA) lifetime incidence is around 2%, with many patients first experiencing symptoms during childhood. However, ritlecitinib is the only FDA-approved treatment for pediatric patients 12 years and older. This review outlines …

  3. Open Access 01-12-2024 | Alopecia Areata | OriginalPaper

    Genetic links between atopy, allergy, and alopecia areata: insights from a Mendelian randomization study

    Alopecia areata (AA), an autoimmune disorder resulting in non-scarring hair loss, impacts about 2% of the global population [ 1 ], predominantly affecting individuals under 40 years, with a noticeable prevalence in Asian communities [ 2 ]. The …

  4. 01-07-2024 | Alopecia Areata | Letter

    Effectiveness and safety of generic tofacitinib in alopecia areata: is the generic a cost-effective option? A retrospective study

  5. Open Access 16-04-2024 | Alopecia Areata | OriginalPaper

    The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016

    Alopecia areata (AA) is an autoimmune disease with an underlying immunoinflammatory pathogenesis [ 1 ]. AA presents as nonscarring hair loss ranging from small patches (alopecia focalis) to complete scalp (alopecia totalis [AT]) or scalp, face, and …

  6. Open Access 10-04-2024 | Calcineurin Inhibitors | OriginalPaper

    Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study

    Alopecia areata (AA) is an autoimmune disorder characterized by non-scarring hair loss that affects approximately 2% of the general population, including all ethnic, gender, and age groups [ 1 – 3 ]. The disease results in significant psychosocial …

  7. Open Access 29-03-2024 | Alopecia Areata | Online First

    Estimation of health utility values for alopecia areata

    Alopecia areata (AA) is an autoimmune-mediated inflammatory dermatological disease characterised by non-scarring hair loss, frequently involving the scalp but sometimes other hair-bearing sites, including eyebrows, eyelashes, facial and body hair …

  8. Open Access 21-03-2024 | Alopecia Areata | Report

    Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries

    Alopecia areata (AA) is an autoimmune condition characterized by non-scarring hair loss, which can vary from small, well-defined patches to extensive, or even total, hair loss on the scalp, face, and/or body [ 1 ]. The lifetime incidence of AA is …

  9. Open Access 23-01-2024 | Alopecia Areata | OriginalPaper

    Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program

    Alopecia areata (AA) is an autoimmune disease with an underlying immuno-inflammatory pathogenesis that is characterized by nonscarring hair loss ranging from small bald patches to complete loss of scalp, face, and/or body hair [ 1 ]. AA has an …

  10. Open Access 01-03-2024 | Valproate | OriginalPaper

    Topical sodium valproate-loaded nanospanlastics versus conventional topical steroid therapy in alopecia areata: a randomized controlled study

    Alopecia areata (AA) is an auto-immune inflammatory disorder with a tremendous negative impact on patients’ quality of life, psychological status and self-esteem [ 1 ]. It has a quite unpredictable prognosis and can run a chronic course with …

  11. Open Access 11-12-2023 | Alopecia Areata | OriginalPaper

    Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey

    Alopecia areata (AA) is a relatively common non-scarring hair loss disease characterized by an autoimmune response [ 1 ]. The 2017 Japanese Dermatological Association (JDA) guidelines categorize patients into five groups (S1–5) according to the …

  12. 09-08-2023 | TNF-Inhibitors | Letter

    Examining the link between TNF inhibition and alopecia areata using Mendelian randomization

  13. Open Access 01-12-2023 | Alopecia | OriginalPaper

    Granuloma annulare with alopecia areata in a 6-year-old girl: a case report

    Granuloma annulare (GA) is a benign cutaneous idiopathic condition, consisting of generalized and localized forms with polymorphic manifestations [ 1 ]. GA has been linked to thyroid disease, diabetes, collagen vascular disease, dyslipidemia …

  14. Open Access 13-10-2023 | Alopecia Areata | ReviewPaper

    Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review

    Treatments for alopecia areata (AA) have traditionally been prescribed off-label, and there has been no universal agreement on how to best manage the condition. Baricitinib is the first oral selective Janus kinase (JAK) inhibitor approved for the …

  15. Open Access 22-11-2023 | Alopecia Areata | OriginalPaper

    Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata

    Alopecia areata (AA) is an autoimmune disorder characterized by nonscarring hair loss that can affect any hair-bearing site [ 1 ], often leading to emotional and psychosocial distress [ 2 – 4 ]. Severe AA is unlikely to remit without treatment [ 5 …

  16. 01-12-2023 | Alopecia | ReviewPaper

    Laser and light therapy combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials

    We aim to evaluate the clinical efficacy and safety of using laser and light combined with topical minoxidil for alopecia areata. We searched PubMed, Embase, Web of Science, the Cochrane Library, China National Knowledge Infrastructure (CNKI) …

  17. Open Access 27-10-2023 | Alopecia Areata | OriginalPaper

    Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries

    Alopecia areata (AA) is an immune-mediated condition that causes non-scarring hair loss [ 1 ]. AA-associated hair loss can range from one or several patches to complete scalp and body hair loss. However, AA has broader impacts beyond hair loss; …

  18. 22-08-2023 | Alopecia Areata | ReviewPaper

    Alopecia Areata: Current Treatments and New Directions

    Alopecia areata is an autoimmune hair loss disease that is non-scarring and is characterized by chronic inflammation at the hair follicle level. Clinically, patients’ presentation varies from patchy, circumscribed scalp involvement to total body …

  19. 08-09-2023 | Alopecia Areata | OriginalPaper

    Associations between season, climate, and pediatric alopecia areata flares in Providence, Rhode Island

    Patients with alopecia areata (AA) may experience episodic hair loss that follows seasonal patterns. To assess associations between seasonal variation, climate factors, and AA flare frequency in pediatric AA patients, we performed a retrospective …

  20. Open Access 23-09-2023 | Alopecia Areata | OriginalPaper

    Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2

    Alopecia areata (AA) is a chronic, autoimmune condition characterized by nonscarring hair loss with a broad spectrum of clinical presentations from localized patches to more extensive scalp hair loss [ 1 – 3 ]. While it predominantly affects the …

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.